GOLGI COMPLEX ANTIBODIES AND AUTOANTIGENS
高尔基复合体抗体和自身抗原
基本信息
- 批准号:6718346
- 负责人:
- 金额:$ 17.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-09-01 至 2005-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Autoantibodies to the Golgi complex are found primarily in patients with Sjgren's syndrome and SLE although they are not restricted to these diseases. This competitive renewal application requests funding for the continuation of studies to characterize autoantigens of the Golgi complex and address the mechanisms that lead to the expression of autoantibodies to these intracellular organelle-associated proteins. The P.I.'s laboratory has been responsible for the identification of a family of Golgi antigens known as golgins. Common features of these autoantigens are that they are located on the cytoplasmic face of the Golgi cisternae and they have multiple alpha-helical coiled-coil rod domains flanked by non-coiled-coil and C- terminal domains. The goal of the proposed studies is to determine if the common structure and function for members of this protein family can explain the origin and production of autoantibodies in disease states. Specific Aim 1 will examine common features of golgins that may explain why they are targets of human anti-Golgi autoantibodies. The P.I. will characterize the events associated with the Golgi complex and golgins and their stability during apoptosis and necrosis. Hypotheses on how these autoantibodies may be produced in experimental models will be examined. Specific Aim 2 will examine if Golgi fragments and vesicular structures will induce immune and autoimmune response in experimental mice. Specific Aim 3 will elucidate the target of Golgi complex in lactate dehydrogenase-elevating virus (LDV) infected mice and address mechanism of how autoimmune response to the Golgi complex can be produced in these mice. Earlier studies have shown that LDV infected mice produce anti-Golgi antibodies. Our current data suggest that the autoimmune response to cytoplasmic organelles such as the Golgi complex is uniquely different from other intracellular autoantigens examined to date. It is anticipated that testing of the P.I.'s hypotheses will provide new insights into autoimmunity and autoimmune diseases associated with subcellular organelles.
高尔基复合体的自身抗体主要见于Sj患者格林综合征和SLE,尽管它们不限于这些疾病。 这项竞争性更新申请要求资助继续研究,以表征高尔基复合体的自身抗原,并解决导致这些细胞内细胞器相关蛋白的自身抗体表达的机制。 私家侦探的实验室负责鉴定一个被称为golgins的高尔基体抗原家族。 这些自身抗原的共同特征是它们位于高尔基体池的胞质面上,并且它们具有多个α螺旋卷曲螺旋杆结构域, 和C-末端结构域。 拟议研究的目标是确定该蛋白质家族成员的共同结构和功能是否可以解释疾病状态下自身抗体的起源和产生。 具体目标1将检查高尔基体的共同特征,这可能解释为什么它们是人类抗高尔基体自身抗体的靶点。 私家侦探将表征与高尔基复合体和高尔基蛋白相关的事件及其在凋亡和坏死期间的稳定性。 将检查关于这些自身抗体如何在实验模型中产生的假设。 具体目标2将检查高尔基体片段和囊泡结构是否会在实验小鼠中诱导免疫和自身免疫应答。 具体目标3将阐明乳酸脱氢酶升高病毒(LDV)感染小鼠中高尔基复合体的靶点,并阐明这些小鼠中如何产生对高尔基复合体的自身免疫应答的机制。 早期的研究表明,LDV感染的小鼠产生抗高尔基体抗体。我们目前的数据表明,细胞质细胞器,如高尔基复合体的自身免疫反应是独特的不同于其他细胞内自身抗原检查日期。预计P.I.的假说将为亚细胞器相关的自身免疫和自身免疫性疾病提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD K CHAN其他文献
EDWARD K CHAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD K CHAN', 18)}}的其他基金
Dominant microRNAs as biomarkers in innate immunity and periodontitis
主要 microRNA 作为先天免疫和牙周炎生物标志物
- 批准号:
10337051 - 财政年份:2019
- 资助金额:
$ 17.76万 - 项目类别:
Dominant microRNAs as biomarkers in innate immunity and periodontitis
主要 microRNA 作为先天免疫和牙周炎生物标志物
- 批准号:
10529344 - 财政年份:2019
- 资助金额:
$ 17.76万 - 项目类别:
Dominant microRNAs as biomarkers in innate immunity and periodontitis
主要 microRNA 作为先天免疫和牙周炎生物标志物
- 批准号:
10063992 - 财政年份:2019
- 资助金额:
$ 17.76万 - 项目类别:
International Workshop on Autoantibodies & Autoimmunity
自身抗体国际研讨会
- 批准号:
7059282 - 财政年份:2005
- 资助金额:
$ 17.76万 - 项目类别:
APPLIED BISYSTEMS PRISM 3100 GENETIC ANALYZER
APPLIED BISYSTEMS PRISM 3100 遗传分析仪
- 批准号:
6440153 - 财政年份:2002
- 资助金额:
$ 17.76万 - 项目类别:
Novel Proteins Associated with SS-A/Ro in Target Organs
靶器官中与 SS-A/Ro 相关的新型蛋白质
- 批准号:
6632306 - 财政年份:2001
- 资助金额:
$ 17.76万 - 项目类别:
Antigens of the RNA-induced silencing complex in autoimmunity
自身免疫中RNA诱导的沉默复合物的抗原
- 批准号:
7336803 - 财政年份:2001
- 资助金额:
$ 17.76万 - 项目类别:
Antigens of the RNA-induced silencing complex in autoimmunity
自身免疫中RNA诱导的沉默复合物的抗原
- 批准号:
7560044 - 财政年份:2001
- 资助金额:
$ 17.76万 - 项目类别:
Novel Proteins Associated with SS-A/Ro in Target Organs
靶器官中与 SS-A/Ro 相关的新型蛋白质
- 批准号:
6708357 - 财政年份:2001
- 资助金额:
$ 17.76万 - 项目类别:
Antigens of the RNA-induced silencing complex in autoimmunity
自身免疫中RNA诱导的沉默复合物的抗原
- 批准号:
7740863 - 财政年份:2001
- 资助金额:
$ 17.76万 - 项目类别:
相似海外基金
MFB: Partnerships to Transform Emerging Industries - RNA Tools/Biotechnology: Stabilizing Hairpin Inserts in RNA Virus Induced Gene Silencing Vectors
MFB:合作变革新兴产业 - RNA 工具/生物技术:稳定 RNA 病毒诱导基因沉默载体中的发夹插入
- 批准号:
2330663 - 财政年份:2024
- 资助金额:
$ 17.76万 - 项目类别:
Standard Grant
Ultrasensitive, Rapid, Amplification-Free RNA Virus Detection Using Nanodimer-Based Nucleic Acid Target Sequence Recognition
使用基于纳米二聚体的核酸靶序列识别进行超灵敏、快速、无扩增的 RNA 病毒检测
- 批准号:
2232940 - 财政年份:2023
- 资助金额:
$ 17.76万 - 项目类别:
Standard Grant
Manipulation of lipid metabolism in (+)RNA virus replication
( )RNA 病毒复制中脂质代谢的调控
- 批准号:
10737240 - 财政年份:2023
- 资助金额:
$ 17.76万 - 项目类别:
3D multi-target imaging of RNA virus replication deep in cells at the nanoscale
纳米级细胞深处 RNA 病毒复制的 3D 多目标成像
- 批准号:
576850-2022 - 财政年份:2022
- 资助金额:
$ 17.76万 - 项目类别:
Alliance Grants
RNA-mediated Regulation of RNA Virus Replication
RNA 介导的 RNA 病毒复制调控
- 批准号:
RGPIN-2020-06167 - 财政年份:2022
- 资助金额:
$ 17.76万 - 项目类别:
Discovery Grants Program - Individual
RNA virus capture of host chemokines: Understanding novel viral mechanisms of immune manipulation
RNA病毒捕获宿主趋化因子:了解免疫操纵的新病毒机制
- 批准号:
10452788 - 财政年份:2022
- 资助金额:
$ 17.76万 - 项目类别:
BSL3 Enhancements for RNA Virus Pandemic Preparedness
BSL3 针对 RNA 病毒大流行防范的增强
- 批准号:
10611745 - 财政年份:2022
- 资助金额:
$ 17.76万 - 项目类别:
RNA virus capture of host chemokines: Understanding novel viral mechanisms of immune manipulation
RNA病毒捕获宿主趋化因子:了解免疫操纵的新病毒机制
- 批准号:
10551229 - 财政年份:2022
- 资助金额:
$ 17.76万 - 项目类别:
Research on the development of nuclear medicine methods to specifically diagnose RNA virus diseases and the therapeutic agents
特异性诊断RNA病毒疾病的核医学方法及治疗药物的研究
- 批准号:
22K07726 - 财政年份:2022
- 资助金额:
$ 17.76万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Quality and evolutionary control of RNA virus genome via nonsense mediated mRNA decay
通过无义介导的 mRNA 衰减对 RNA 病毒基因组进行质量和进化控制
- 批准号:
22K20759 - 财政年份:2022
- 资助金额:
$ 17.76万 - 项目类别:
Grant-in-Aid for Research Activity Start-up